{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:57:45Z","timestamp":1760061465709,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejso.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T12:40:26Z","timestamp":1521376826000},"page":"1151-1156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9137-7599","authenticated-orcid":false,"given":"Ingrid G.M.","family":"Poodt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolijn L.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guusje","family":"Vugts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit E.P.J.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grard A.P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert-Jan","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.03.003_bib1","article-title":"Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS era","author":"Poodt","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.03.003_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","article-title":"Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy","volume":"16","author":"Rescigno","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.03.003_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.03.003_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14656566.6.7.1055","article-title":"Controversies in breast cancer: adjuvant and neoadjuvant therapy","volume":"6","author":"Montemurro","year":"2005","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.ejso.2018.03.003_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.03.003_bib7","unstructured":"Nationaal Borstkanker Overleg Nederland (NABON). Richtlijn behandeling van het mammacarcinoom. editor\u02c6, editors\". City; Accessed 2 March 2012."},{"key":"10.1016\/j.ejso.2018.03.003_bib8","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2015.65.8609","article-title":"Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: american society of clinical oncology endorsement of cancer care ontario guideline recommendations","volume":"34","author":"Henry","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib9","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1016\/S1470-2045(16)30311-4","article-title":"De-escalation of axillary surgery in early breast cancer","volume":"17","author":"Jatoi","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib10","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1200\/JCO.2017.74.0472","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: american society of clinical oncology clinical practice guideline focused update","volume":"35","author":"Krop","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2018.03.003_bib12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies\u2013improving the management of early breast cancer: st Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.24516","article-title":"Clinical auditing as an instrument for quality improvement in breast cancer care in The Netherlands: the national NABON Breast Cancer Audit","volume":"115","author":"van Bommel","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-016-3940-7","article-title":"Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level","volume":"159","author":"Verschoor","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2018.03.003_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","article-title":"Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer","volume":"28","author":"Straver","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2016.05.005","article-title":"Omission of axillary dissection after a positive sentinel lymph-node: implications in the multidisciplinary treatment of operable breast cancer","volume":"48","author":"Ponzone","year":"2016","journal-title":"Canc Treat Rev"},{"key":"10.1016\/j.ejso.2018.03.003_bib19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1245\/s10434-012-2798-0","article-title":"Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations","volume":"20","author":"Aigner","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib20","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1245\/s10434-012-2505-1","article-title":"Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients","volume":"19","author":"Montemurro","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1245\/s10434-007-9670-7","article-title":"How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis","volume":"15","author":"Reimer","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000126073","article-title":"Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status","volume":"77","author":"Joosten","year":"2008","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.ejso.2018.03.003_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American cancer society\/American society of clinical oncology breast cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/sj.bjc.6601150","article-title":"Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients","volume":"89","author":"Peintinger","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2018.03.003_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2018.03.003_bib26","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"Suppl 2","key":"10.1016\/j.ejso.2018.03.003_bib27","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.breast.2015.07.035","article-title":"Long term side effects of adjuvant chemotherapy in patients with early breast cancer","volume":"24","author":"Tao","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2018.03.003_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.03.003_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejca.2017.07.042","article-title":"Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area","volume":"84","author":"Schreuder","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2018.03.003_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0031-1298595","article-title":"Assessing bias: the importance of considering confounding","volume":"3","author":"Skelly","year":"2012","journal-title":"Evid Base Spine Care J"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831830948X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879831830948X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:26:18Z","timestamp":1760059578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879831830948X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S074879831830948X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.03.003","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}